Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis

Riccardo Candido1, Michela Zanetti

  • 1Diabetology Center, Azienda per i Servizi Sanitari n. 1 Triestina, Italy.

Insights

Diabetes significantly increases cardiovascular risks due to endothelial dysfunction, a key factor in atherosclerosis development and progression. This review explores its causes, links to risk factors, and potential treatments.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Vascular Biology

Background:

  • Cardiovascular complications are the primary cause of mortality in diabetic patients.
  • Endothelial dysfunction is an early and critical step in atherosclerosis development, progression, and clinical manifestation.
  • Endothelial dysfunction involves impaired vasodilation and an activated endothelium, creating a pro-inflammatory, proliferative, and procoagulatory state that drives atherogenesis.

Purpose of the Study:

  • To review the multifactorial nature of endothelial dysfunction in diabetes.
  • To examine the relationship between endothelial dysfunction, cardiovascular risk factors, and atherosclerosis.
  • To discuss therapeutic strategies for improving endothelial function in diabetic individuals.

Main Methods:

  • Literature review of studies on endothelial dysfunction in diabetes.
  • Analysis of the interplay between diabetes, conventional cardiovascular risk factors, and endothelial function.
  • Synthesis of current understanding of atherogenesis mechanisms in diabetes.

Main Results:

  • Endothelial dysfunction is a central mechanism linking diabetes to accelerated atherosclerosis.
  • Synergistic interactions among diabetes-related cardiovascular risk factors exacerbate endothelial dysfunction and vascular damage.
  • The pro-inflammatory and pro-thrombotic state of endothelial activation promotes cardiovascular events.

Conclusions:

  • Endothelial dysfunction is a critical, multifactorial contributor to cardiovascular complications in diabetes.
  • Targeting endothelial dysfunction offers a promising therapeutic avenue for managing cardiovascular risk in diabetes.
  • Further research is needed to elucidate specific mechanisms and optimize treatment strategies.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...